NCT03636633

Brief Summary

During the past decade, especially with the advancement of technology, major innovations and developments have been observed in the field of surgery. Cardiac surgery is one of the important area of the surgery who renews itself day by day and adds innovations to the nature in terms of patients' comfort. One of the greatest developments in cardiac surgery in this sense is the tendency to reduce the size of the incisions with less interventional procedures. Robotic surgery is getting more and more meaningful in this area. Despite the downsizing of the surgical incisions, postoperative pulmonary complications have not completely disappeared in the robotic cardiac surgery. Major respiratory problems following traditional cardiac surgery are gas exchange problems, atelectasis, decreased coughing force and sputum retention. The effectiveness of respiratory physiotherapy applied after traditional cardiac surgery for the resolution of these complications has been proved by various investigations. Inspiratory muscle training (IMT) has been found to improve autonomic modulation in heart failure patients as well as to increase inspiratory muscle strength in applied patient populations, reduce blood pressure in hypertensive patients, and increase functional capacity in elderly individuals. Considering these benefits, when inspiratory muscle training is given to people with traditional cardiac surgery, respiratory muscle strengths, respiratory functions and functional capacities are increased compared to those not given to these patients. However, although there are complications after robotic cardiac surgery, there are no studies in the literature about respiratory physiotherapy or inspiratory muscle training. Thus, the subject of this study is the comparison of the effects of standard respiratory physiotherapy and standard respiratory physiotherapy plus inspiratory muscle training on the respiratory functions, respiratory muscle strength and functional capacity of the patients with the robotic heart surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 21, 2018

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 6, 2018

Completed
11 days until next milestone

First Posted

Study publicly available on registry

August 17, 2018

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 21, 2019

Completed
1.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 21, 2021

Completed
Last Updated

April 29, 2022

Status Verified

April 1, 2022

Enrollment Period

1 year

First QC Date

August 6, 2018

Last Update Submit

April 25, 2022

Conditions

Keywords

Robotic Heart SurgeryInspiratory Muscle TrainingPulmonary Function Test6-Minute Walk TestRespiratory Muscle StrengthFunctional Capacity

Outcome Measures

Primary Outcomes (7)

  • Change from baseline Forced Vital Capacity (FVC) at 4 weeks

    Four weeks

  • Change from baseline Forced Expiratory Volume in 1 second (FEV1) at 4 weeks

    Four weeks

  • Change from baseline Peak Expiratory Flow (PEF) at 4 weeks

    Four weeks

  • Change from baseline maximum inspiratory pressure (MIP) at 4 weeks

    Four weeks

  • Change from baseline maximum expiratory pressure (MEP) at 4 weeks

    Four weeks

  • Change from baseline distance covered in six-minute walk test (6MWT) at 4 weeks

    Four weeks

  • Change from baseline carbon monoxide diffusion capacity of the lungs (DLCO) at 4 weeks

    Four weeks

Secondary Outcomes (2)

  • Fatigue Severity Scale

    Four weeks

  • Fatigue Impact Scale

    Four weeks

Study Arms (2)

Control Group

ACTIVE COMPARATOR

Standard respiratory physiotherapy Patients in this group will receive standard respiratory physiotherapy two times a day, 7 days a week for 4 weeks. During hospitalization, sessions will be performed by a respiratory physiotherapist. After discharge, other sessions will be performed at home by themselves.

Other: Standard respiratory physiotherapy

Training Group

EXPERIMENTAL

Standard respiratory physiotherapy and inspiratory muscle train In addition to the standard respiratory physiotherapy program, patients in this group will receive 3 sets of inspiratory muscle training with 10 repetitions twice a day for 4 weeks. During hospitalization, sessions will be performed by a respiratory physiotherapist. After discharge, other sessions will be performed at home by themselves.

Other: Standard respiratory physiotherapy and inspiratory muscle training

Interventions

Standard respiratory physiotherapy content; diaphragmatic breathing, pursed lip breathing, segmental breathing, incentive spirometer exercises (Triflo) and coughing techniques.

Control Group

Standard respiratory physiotherapy content; diaphragmatic breathing, pursed lip breathing, segmental breathing, incentive spirometer exercises (Triflo) and coughing techniques. Addition to that, threshold IMT device will be used for the training. Training intensity will set at 40% of the maximum inspiratory pressure.

Training Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being suitable for robotic cardiac surgery,
  • Being hospitalized to have a robotic heart surgery,
  • No complications during surgery,
  • To be extubated in intensive care unite after surgery ,
  • Stable clinical condition,
  • To be transferred from ICU to the hospital room on the first day after surgery.

You may not qualify if:

  • Chronic obstructive pulmonary disease,
  • Unstable angina,
  • Acute decompensated heart failure,
  • Acute pericarditis and myocarditis,
  • Complex arrhythmia,
  • Uncontrolled hypertension,
  • Serious orthopedic and neurological impairment,
  • Uncontrolled diabetes,
  • Body Mass Index \> 30.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Acıbadem MAA University Maslak Hospital

Istanbul, 34457, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Heart Diseases

Condition Hierarchy (Ancestors)

Cardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PT, Research Assistant at Faculty of Health Sciences, Acibadem University

Study Record Dates

First Submitted

August 6, 2018

First Posted

August 17, 2018

Study Start

March 21, 2018

Primary Completion

March 21, 2019

Study Completion

February 21, 2021

Last Updated

April 29, 2022

Record last verified: 2022-04

Locations